Biolase Technology (BLTI) Posts Q4 Loss of 4c/Share; Guides Q1 Revs Below
Get Alerts BLTI Hot Sheet
Join SI Premium – FREE
Biolase Technology, Inc. (NASDAQ: BLTI) reported Q4 EPS of ($0.04), $0.02 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $13.14 million versus the consensus estimate of $13.1 million.
Sees FY2012 revenue of $11 million, versus the consensus of $13.2 million.
For earnings history and earnings-related data on Biolase Technology, Inc. (BLTI) click here.
Sees FY2012 revenue of $11 million, versus the consensus of $13.2 million.
For earnings history and earnings-related data on Biolase Technology, Inc. (BLTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FreightCar America (RAIL) Misses Q4 EPS by 6c, provides guidance
- Red Cat Holdings Inc. (RCAT) Misses Q3 EPS by 5c
- Augmedix, Inc. (AUGX) Tops Q4 EPS by 1c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!